RedHill Biopharma Ltd. of TEL AVIV, L3, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-05. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 33 people.
| Name | Role | Location |
|---|---|---|
| Dror Ben-Asher | Director | Tel Aviv, L3 |
| Shmuel Cabilly | Director | Tel Aviv, L3 |
| Alla Felder | Director | Tel Aviv, L3 |
| Kenneth Reed | Director | Waltham, MA |
| Rick Scruggs | Director | Tel Aviv, L3 |
| Eric Swenden | Director | Tel Aviv, L3 |
| Ofer Tsimchi | Director | Tel Aviv, L3 |
| Dror Ben-Asher | Executive Officer | Tel Aviv, L3 |
| Reza Fathi | Executive Officer | Tel Aviv, L3 |
| Adi Frish | Executive Officer | Tel Aviv, L3 |
| Guy Goldberg | Executive Officer | Tel Aviv, L3 |
| Razi Ingber | Executive Officer | Tel Aviv, L3 |
| Gilead Raday | Executive Officer | Tel Aviv, L3 |
| Rick Scruggs | Executive Officer | Tel Aviv, L3 |
| Micha Ben Chorin | Executive Officer | Tel Aviv, L3 |
| June Almenoff | Executive Officer | Tel Aviv, L3 |
| June D Almenoff | Executive Officer | TEL AVIV, L3 |
| Rick D Scruggs | Director | TEL AVIV, L3 |
| Rick D Scruggs | Executive Officer | TEL AVIV, L3 |
| Nicolas D Weinstein | Director | TEL AVIV, L3 |
| Alla D Felder | Director | TEL AVIV, L3 |
| Micha D Ben Chorin | Executive Officer | TEL AVIV, L3 |
| Adi D Frish | Executive Officer | TEL AVIV, L3 |
| Gilead D Raday | Executive Officer | TEL AVIV, L3 |
| Guy D Goldberg | Executive Officer | TEL AVIV, L3 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-10-12 | D | $4.0M | $4.0M |
| 2023-08-07 | D | $2.7M | $2.7M |
| 2021-11-22 | D | $10.0M | $5.0M |
| 2019-11-06 | D | $48.3M | $48.3M |
| 2014-01-15 | D | $2.5M | $2.5M |